Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Gastroesophageal Reflux Disease (GERD) Device Market Outlook

Around US$ 1207.3 million is projected to be the value of global sales of gastroesophageal reflux disease (GERD) device in 2024. By 2034, the gastroesophageal reflux disease (GERD) device market is anticipated to advance at a 3.6% CAGR and surpass a valuation of US$ 1719.5 million. The increasing prevalence of GERD and the development of less invasive treatment options are projected to contribute to the gastroesophageal reflux disease device market's steady rise.

Technological advancements such as endoscopic therapy and magnetic sphincter augmentation devices are becoming a growing trend since they provide efficient substitutes for conventional surgical and pharmaceutical methods. The gastroesophageal reflux disease (GERD) device market is expanding due to patients and healthcare professionals becoming conscious of the advantages of these devices, which include quicker recovery times and enhanced quality of life.

Attributes Details
Market Value for 2024 US$ 1207.3 million
Market Value for 2034 US$ 1719.5 million
Market CAGR from 2024 to 2034 3.6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Growth Avenues in the Gastroesophageal Reflux Disease (GERD) Device Market

  • Due to parameters like patient preference, cost-effectiveness, and convenience, ambulatory care and outpatient operations are progressively prevalent. This trend is particularly suited for gastroesophageal reflux disease (GERD) devices utilized in minimally invasive treatments or outpatient settings.
  • Pressure is on healthcare systems to reduce costs and enhance patient outcomes. In the long run, gastroesophageal reflux disease (GERD) devices that provide long-term symptom alleviation and lessen the requirement for continued medication or repeated procedures are likely to save money.
  • Patients and healthcare professionals are now more aware of GERD and its possible consequences, which has resulted in earlier diagnosis and treatment commencement. This facilitates the adoption of gastroesophageal reflux disease devices by creating a favorable atmosphere.
Attributes Details
Market Value for 2019 US$ 1001 million
Market Value for 2023 US$ 1213.4 million
Market CAGR from 2019 to 2023 3.9%

Impediments Impacting the Gastroesophageal Reflux Disease (GERD) Device Industry

  • Many people with GERD symptoms are unaware that they have the illness, which results in underdiagnosis and undertreatment. Insufficient knowledge among patients and medical professionals impedes the adoption of GERD devices.
  • GERD device reimbursement policies is complicated and varied amongst healthcare systems. Patient access and healthcare provider uptake are hampered by limited coverage and reimbursement choices.
  • New GERD devices cannot reach the market sooner due to drawn-out approval processes caused by strict regulatory regulations and the demand for extensive clinical data. This acts as an impediment to gastroesophageal reflux disease (GERD) device market expansion.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of Adjacent Gastroesophageal Reflux Disease (GERD) Device Market

The gastroesophageal reflux disease therapeutics market and the medical device technologies market have both been studied by Future Market Insights (FMI). The data depict the projected growth of the GERD device market from 2024 to 2034 in other markets. It showcases the potential for revenue in the additional markets shown below.

Gastroesophageal Reflux Disease (GERD) Device Market:

Attributes Gastroesophageal Reflux Disease (GERD) Device Market
Value-based CAGR (2024 to 2034) 3.6%
Growth Factor The gastroesophageal reflux disease (GERD) device market is growing due to increased demand for less intrusive GERD therapies.
Market Trend Modern anti-reflux gadgets advance market growth of gastroesophageal reflux disease (GERD) device.
Market Restraint The broader adoption of gastroesophageal reflux disease (GERD) devices is hampered by limited insurance coverage.

Gastroesophageal Reflux Disease Therapeutics Market:

Attributes Gastroesophageal Reflux Disease Therapeutics Market
Value-based CAGR (2024 to 2034) 3%
Growth Factor Globally, the prevalence of gastroesophageal reflux diseases is rising.
Market Trend An aging population is one factor raising the occurrence of gastroesophageal reflux diseases.
Market Restraint Patent expirations impose pressure on prices and generic competition.

Medical Device Technologies Market:

Attributes Medical Device Technologies Market
Value-based CAGR (2024 to 2034) 6.4%
Growth Factor An increase in the prevalence of chronic illnesses calls for the growth of novel medical device technologies.
Market Trend Switch toward value-based healthcare models that provide remote monitoring and preventative care.
Market Restraint Growing concerns about cybersecurity and data privacy in connected medical equipment.

Category-wise Outlook

The segmented study of the gastroesophageal reflux disease (GERD) device market is detailed in the part below. Extensive research demonstrates that diagnostic procedures are at the forefront of procedural innovations, with esophagoscopes and gastroscopes commanding the product segment.

This comprehensive analysis sheds light on the constantly shifting landscape of GERD management, identifying major trends and in the gastroesophageal reflux disease device market.

The Leading Role of Esophagoscopes and Gastroscopes in GERD Device Market

Segment Esophagoscopes and Gastroscopes
Share (2024) 90%
  • Esophagoscopy and gastroscopy segments are crucial diagnostic instruments that provide exact vision to detect and manage GERD accurately.
  • The business need for effective diagnostic procedures drives sales of gastroscopes and esophagoscopes in the gastroesophageal reflux disease (GERD) device market.
  • As a crucial component of the diagnostic toolkit, gastroscopes and esophagoscopes support market leadership by meeting the increasing demand for sophisticated GERD evaluation.

Diagnostic Procedures Shaping GERD Treatment Paradigms

Segment Diagnostic Procedures
Share (2024) 68%
  • Healthcare providers' need is encouraged by the demand for GERD device diagnostic techniques, which provide crucial insights for customized treatment programs.
  • Diagnostic technology investments are drawing investors and healthcare providers as they align with the increased emphasis on value-based healthcare.
  • The leading position in gastroesophageal reflux disease (GERD) device sales of the diagnostic procedures category highlights its critical function in determining the treatment options available for GERD.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Analysis

The GERD device market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for gastroesophageal reflux disease device.

Opportunities in the Asia Pacific Gastroesophageal Reflux Disease (GERD) Device Industry

Countries CAGR (2024 to 2034)
India 5.2%
Thailand 5.0%
Malaysia 4.6%
Indonesia 3.4%

India Industry Outlook

  • The gastroesophageal reflux disease (GERD) device industry in India likely expand even more due to government attempts to encourage medical travel and draw in foreign investment in the medical field.
  • There is an increasing need for novel and reasonably priced devices in India as the number of GERD cases being identified and treated rises.

Thailand Industry Outlook

  • As Thailand grows in popularity as a destination for medical treatments, the country's growing medical tourism industry is fueling the demand for gastroesophageal reflux disease (GERD) devices.
  • The adoption of GERD devices in Thailand is boosted by a growing patient and healthcare professional awareness of GERD and its treatment alternatives.

Malaysia Industry Outlook

  • Adopting cutting-edge medical treatments and technologies governs the demand for GERD devices in Malaysia's healthcare industry.
  • Malaysian individuals' and healthcare professionals' growing awareness of GERD and its repercussions surges the GERD device market.

Indonesia Industry Outlook

  • The increased prevalence of GERD is caused by changes in living choices and rising disposable income, which is propelling the gastroesophageal reflux disease device market in Indonesia.
  • The adoption of GERD devices is increasing in Indonesia due to patients' and healthcare providers' growing knowledge of GERD and available treatments.

Insights into Sales Performance of Gastroesophageal Reflux Disease (GERD) Device in North America

Countries CAGR (2024 to 2034)
United States 2.6%
Canada 2.9%

United States Industry Outlook

  • The gastroesophageal reflux disease (GERD) device market dynamics are significantly shaped by health insurance coverage and reimbursement policies in the United States, which affects patient accessibility and affordability.
  • The emphasis on enhancing quality of life and patient preference for non-surgical alternatives are important reasons propelling the adoption of GERD devices in the United States.

Canada Industry Outlook

  • A wider adoption of GERD devices is supported by the Canadian healthcare system's emphasis on universal access to medical services, which guarantees fair availability for patients from various demographic backgrounds.
  • The introduction and adoption of gastroesophageal reflux disease devices in Canada are significantly shaped by regulatory frameworks and approval procedures prioritizing safety and efficacy.

Opportunities for Gastroesophageal Reflux Disease (GERD) Device Market in Europe

Countries CAGR (2024 to 2034)
Germany 1.9%
United Kingdom 1.6%
France 2.3%
Italy 2.0%
Spain 2.9%

Germany Industry Outlook

  • The demand for GERD devices is expanding in Germany due to proactive healthcare activities and increased awareness.
  • Significant industry participants and a strong regulatory environment bolster German gastroesophageal reflux disease (GERD) device sales.
  • The Germany gastroesophageal reflux disease (GERD) device market is growing due to rising GERD prevalence and strong patient acceptance of minimally invasive procedures.

United Kingdom Industry Outlook

  • Growing rates of GERD are encouraging market expansion in the United Kingdom due to the adoption of new medical technology.
  • Proactive health education campaigns raise awareness and encourage early intervention, influencing the United Kingdom's sales of gastroesophageal reflux disease (GERD) device.

France Industry Outlook

  • The growing awareness of GERD by the general public and healthcare professionals contributes to the French demand for modern GERD devices.
  • The gastroesophageal reflux disease device market in France benefits from a rising emphasis on customized treatment solutions and a trend toward personalized medicine.

Italy Industry Outlook

  • Adopting telemedicine and digital health solutions in Italy has increased gastroesophageal reflux disease (GERD) device accessibility and usage.
  • The growing demand for GERD devices is fueled by Italy's preventative care-focused healthcare system, which presents opportunities for market expansion of gastroesophageal reflux disease (GERD) device.

Spain Industry Outlook

  • A cultural trend in Spain toward proactive health management and a growing acceptance of innovative medical technologies benefit the GERD device market.
  • The gastroesophageal reflux disease device market in Spain demonstrates an increasing need for individualized treatment plans, motivated by a better knowledge of each patient's requirements.

Competitive Analysis

Several prominent gastroesophageal reflux disease device vendors are vying for market share in the highly competitive atmosphere of the industry.

Notable gastroesophageal reflux disease device manufacturers influencing the direction of the business are Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG, Medtronic Plc, Fujifilm Holdings Corporation, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. By addressing the difficulties associated with managing GERD, these gastroesophageal reflux disease device businesses offer a variety of technological expertise, creating a competitive atmosphere centered on enhancing patient outcomes and expanding available treatment options.

Olympus Corporation, Pentax Medical, KARL STORZ SE, and Co KG are improving GERD device technology. This gastroesophageal reflux disease (GERD) device providers are known for their dedication to quality and innovation. Medtronic Plc uses its broad healthcare portfolio to provide comprehensive solutions for managing GERD, while Fujifilm Holdings Corporation contributes its imaging expertise to improve diagnostic capabilities.

By providing specialized tools and methods that address particular patient demands and broaden the range of available treatments, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. make contributions.

Continuous innovation and development in GERD management tactics are expected as these major gastroesophageal reflux disease device vendors cooperate and compete. These gastroesophageal reflux disease device suppliers are essential in influencing the direction of GERD therapy and enhancing the lives of those impacted by the disease by emphasizing patient-centric solutions and technical innovations.

Notable Strides

Company Details
Wockhardt Ltd. Wockhardt Ltd. acquired its authorized generic versions of several over-the-counter medications from Glenmark Pharmaceuticals Ltd. in June 2022. The approved abbreviated new drug applications for famotidine tablets, which are used to treat and prevent stomach and intestinal ulcers, as well as treatment drug Lansoprazole delayed-release capsules USP, 15 mg, are among the medications included in the acquisition by the company's fully owned subsidiary Glenmark Pharmaceuticals Inc, USA.
Zydus Lifesciences The FDA approved Zydus Lifesciences' 20 mg and 40 mg formulations of metronidazole tablets for sale in June 2022. As a histamine H2 receptor blocker, famotidine lowers stomach acid production. The medication is intended to treat and prevent acid reflux disease (GERD) as well as other related symptoms.
Peptest Peptest, a non-invasive radiofrequency device designed by RD Biomed for the diagnosis of reflux devices, was approved by China. This device detects pepsin in saliva samples and helps with the overall treatment of reflux-related devices.
EsophyX Z An improved and more recent version of the EsophyX device is the EsophyX Z gastroesophageal reflux disease device, used to perform transoral incisionless fundoplication.

Prominent Gastroesophageal Reflux Disease (GERD) Device Vendors

  • Olympus Corporation
  • Pentax Medical
  • KARL STORZ SE and Co KG.
  • Medtronic Plc
  • Fujifilm Holdings Corporation
  • EndoGastric Solutions
  • Medigus Ltd.
  • Diversatek Inc.

Key Coverage in GERD Device Market Report

  • Adjacent Study on GERD Device Market, Gastroesophageal Reflux Disease Therapeutics Market, and Medical Device Technologies Market
  • Market Trends Escalating GERD Device Sales
  • Thailand’s Opportunity to Become a Global Frontrunner in Gastroesophageal Reflux Disease (GERD) Device
  • Demand for Gastroesophageal Reflux Disease (GERD) Device in India
  • Strategies for Gastroesophageal Reflux Disease (GERD) Device Vendors
  • Competitive Analysis of Leading Gastroesophageal Reflux Disease (GERD) Device Providers with Focus on Peptest, EsophyX Z, and Others.

Key Segments

By Product:

  • Diagnostic Devices
  • Manometry Systems
  • PH Monitoring Systems
  • Esophagoscopes and Gastroscopes
  • Treatment Devices
  • Ultrasonic Surgical Endostaplers
  • Fundoplication Devices
  • Sphincter Augmentation Devices
  • Radiofrequency Ablation Devices

By Procedure:

  • Diagnostic Procedures
  • Fundoplication Procedures
  • Radiofrequency Thermal Ablation
  • Magnetic Sphincter Augmentation

By End User:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

What is Current Gastroesophageal Reflux Disease (GERD) Device Market Valuation?

The GERD device market to secure a valuation US$ 1207.3 million in 2024.

How Big Can the Gastroesophageal Reflux Disease (GERD) Device Market Be by 2034?

The GERD device market is estimated to attain US$ 1719.5 million by 2034.

What is the Growth Potential of the Gastroesophageal Reflux Disease (GERD) Device Market?

Through 2034, the GERD device market is anticipated to evolve at a 3.6% CAGR.

What Was the Historical Outlook of The Gastroesophageal Reflux Disease (GERD) Device Market?

From 2019 to 2023, the gastroesophageal reflux disease (GERD) device market registered a 3.9% CAGR.

Which Product Segment to Dominate in the Gastroesophageal Reflux Disease (GERD) Device Market?

The esophagoscopes and gastroscopes sector is set to achieve a market share of 90% in 2024.

Which Procedure Segment to Lead the Gastroesophageal Reflux Disease (GERD) Device Market?

A 68% market share is expected for the diagnostic procedures sector in 2024.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Manufacturer

            3.5.1.2. Mid-Level Participants (Traders)

            3.5.1.3. Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Distributors

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034

        5.3.1. Diagnostic Devices

        5.3.2. Manometry Systems

        5.3.3. PH Monitoring Systems

        5.3.4. Esophagoscopes and Gastroscopes

        5.3.5. Treatment Devices

        5.3.6. Ultrasonic Surgical Endostaplers

        5.3.7. Fundoplication Devices

        5.3.8. Sphincter Augmentation Devices

        5.3.9. Radiofrequency Ablation Devices

    5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Procedure

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Procedure, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Procedure, 2024 to 2034

        6.3.1. Diagnostic Procedures

        6.3.2. Fundoplication Procedures

        6.3.3. Radiofrequency Thermal Ablation

        6.3.4. Magnetic Sphincter Augmentation

    6.4. Y-o-Y Growth Trend Analysis By Procedure, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Procedure, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034

        7.3.1. Hospitals

        7.3.2. Diagnostic Centers

        7.3.3. Ambulatory Surgical Centers

    7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Procedure

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Procedure

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Procedure

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Procedure

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product

        11.2.3. By Procedure

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Procedure

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product

        12.2.3. By Procedure

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Procedure

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product

        13.2.3. By Procedure

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Procedure

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Procedure

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Procedure

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Procedure

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Procedure

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2023

            16.1.2.1. By Product

            16.1.2.2. By Procedure

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2023

            16.2.2.1. By Product

            16.2.2.2. By Procedure

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2023

            16.3.2.1. By Product

            16.3.2.2. By Procedure

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2023

            16.4.2.1. By Product

            16.4.2.2. By Procedure

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2023

            16.5.2.1. By Product

            16.5.2.2. By Procedure

            16.5.2.3. By End User

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2023

            16.6.2.1. By Product

            16.6.2.2. By Procedure

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2023

            16.7.2.1. By Product

            16.7.2.2. By Procedure

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2023

            16.8.2.1. By Product

            16.8.2.2. By Procedure

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2023

            16.9.2.1. By Product

            16.9.2.2. By Procedure

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2023

            16.10.2.1. By Product

            16.10.2.2. By Procedure

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2023

            16.11.2.1. By Product

            16.11.2.2. By Procedure

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2023

            16.12.2.1. By Product

            16.12.2.2. By Procedure

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2023

            16.13.2.1. By Product

            16.13.2.2. By Procedure

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2023

            16.14.2.1. By Product

            16.14.2.2. By Procedure

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2023

            16.15.2.1. By Product

            16.15.2.2. By Procedure

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2023

            16.16.2.1. By Product

            16.16.2.2. By Procedure

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2023

            16.17.2.1. By Product

            16.17.2.2. By Procedure

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2023

            16.18.2.1. By Product

            16.18.2.2. By Procedure

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2023

            16.19.2.1. By Product

            16.19.2.2. By Procedure

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2023

            16.20.2.1. By Product

            16.20.2.2. By Procedure

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2023

            16.21.2.1. By Product

            16.21.2.2. By Procedure

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2023

            16.22.2.1. By Product

            16.22.2.2. By Procedure

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2023

            16.23.2.1. By Product

            16.23.2.2. By Procedure

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Procedure

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Olympus Corporation

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Pentax Medical

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. KARL STORZ SE & Co KG.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Medtronic Plc

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Fujifilm Holdings Corporation

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. EndoGastric Solutions

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Medigus Ltd.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Diversatek Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. LABORIE

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Mederi Therapeutics Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Gastroesophageal Reflux Disease Therapeutics Market

Published : November 2022

Explore Healthcare Insights

View Reports

Gastroesophageal Reflux Disease (GERD) Device Market